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Abstract Testing hundreds of thousands of DNA markers
in human, mouse, and other species for association to
complex traits like disease is now a reality. However,
information on how variations in DNA impact complex
physiologic processes ﬂows through transcriptional and
other molecular networks. In other words, DNA variations
impact complex diseases through the perturbations they
cause to transcriptional and other biological networks, and
these molecular phenotypes are intermediate to clinically
deﬁned disease. Because it is also now possible to monitor
transcript levels in a comprehensive fashion, integrating
DNA variation, transcription, and phenotypic data has the
potential to enhance identiﬁcation of the associations be-
tween DNA variation and diseases like obesity and dia-
betes, as well as characterize those parts of the molecular
networks that drive these diseases. Toward that end, we
review methods for integrating expression quantitative trait
loci (eQTLs), gene expression, and clinical data to infer
causal relationships among gene expression traits and be-
tween expression and clinical traits. We further describe
methods to integrate these data in a more comprehensive
manner by constructing coexpression gene networks that
leverage pairwise gene interaction data to represent more
general relationships. To infer gene networks that capture
causal information, we describe a Bayesian algorithm that
further integrates eQTLs, expression, and clinical pheno-
type data to reconstruct whole-gene networks capable of
representing causal relationships among genes and traits in
the network. These emerging network approaches, aimed at
processing high-dimensional biological data by integrating
data from multiple sources, represent some of the ﬁrst steps
in statistical genetics to identify multiple genetic pertur-
bations that alter the states of molecular networks and that
in turn push systems into disease states. Evolving statistical
procedures that operate on networks will be critical to
extracting information related to complex phenotypes like
disease, as research goes beyond a single-gene focus. The
early successes achieved with the methods described herein
suggest that these more integrative genomics approaches to
dissecting disease traits will signiﬁcantly enhance the
identiﬁcation of key drivers of disease beyond what could
be achieved by genetic association studies alone.
Introduction
Genetics is at the dawn of a new era with maturing tech-
nologies that enable low-cost, high-throughput genotyping
of hundreds of thousands of DNA markers that in turn can
be tested for association to complex traits of interest like
disease and drug response. A number of studies have al-
ready leveraged the availability of such technologies to
identify polymorphisms in genes that associate with dis-
eases like age-related macular degeneration (Edwards et al.
2005; Haines 2005; Klein 2005), diabetes (Grant 2006;
Sladek 2007), and obesity (Herbert 2006), to name just a
few. In addition, there are scores of similar genome-wide
association studies that are ongoing and that promise to
deliver scores of genes that harbor variations that associate
with diseases like obesity and diabetes. While these types
of genetic discoveries provide a peek into pathways that
underlie disease, they are usually devoid of context, so that
elucidating the functional role such genes play in disease
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ApoE, an Alzheimer’s susceptibility gene identiﬁed nearly
15 years ago (Peacock et al. 1993).
Information that deﬁnes how variations in DNA that
associate with disease actually impact the complex physi-
ologic processes underlying disease ﬂows through tran-
scriptional and other molecular, cellular, tissue, and
organism networks (Fig. 1). In the past the ability to
comprehensively assess intermediate phenotypes that
comprise the hierarchy of networks that drive disease was
not possible. However, today DNA microarrays have rad-
ically changed the way we study genes, enabling a more
comprehensive look at the role they play in everything
from the regulation of normal cellular processes to com-
plex diseases like obesity and diabetes. In their typical use,
microarrays allow researchers to screen thousands of genes
for differences in expression or differences in how genes
are connected in molecular networks (Schadt and Lum
2006) between experimental conditions of interest. These
data are often used to discover genes that differ between
normal and disease-associated tissue, to model and predict
continuous or binary measures, to predict patient survival,
and to classify disease or tumor subtypes. Because gene
expression levels in a given sample are measured simul-
taneously, researchers are able to identify genes whose
expression levels are correlated, implying an association
under speciﬁc conditions or more generally.
Integrating genetic and functional genomic data can
provide a path to inferring causal associations between
genes and disease. In the past, causal associations between
genes and traits have been investigated using time series
experiments, gene knockouts or transgenics that overex-
Fig. 1 High-level view of the ﬂow of information in biological
systems through a hierarchy of networks. Each panel highlights a
different set of networks at play in a biological system. Genomics
networks represent interactions among DNA sequences that may give
rise to longer-range as well as more local chromosome structures that
modulate gene activity, in addition to inducing synergistic effects on
higher-order phenotypes. Genomics networks drive molecular net-
works composed of RNA, protein, metabolites, and other molecules
in the system. Molecular networks are components of cellular
networks in which the complex web of interactions among these
networks gives rise to the complex phenotypes that deﬁne living
systems. Tissue networks comprise cellular networks that are clearly
inﬂuenced by the molecular and genomics networks, and organism
networks comprise tissue networks that are clearly deﬁned by the
component cellular and molecular networks. Complex phenotypes
like disease emerge from this complex web of interacting networks,
given genetic and environmental perturbations to the system
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123press a gene of interest, RNAi-based knockdown or viral-
mediated overexpression of genes of interest, and chemical
activation or inhibition of genes of interest. A more sys-
tematic and arguably relevant source of perturbation to
make such inferences regarding genes and disease are DNA
polymorphisms, where gene expression and other molec-
ular phenotypes in a number of species have been shown to
be signiﬁcantly heritable and at least partially under the
control of speciﬁc genetic loci (Brem et al. 2002; DeCook
et al. 2006; Hubner et al. 2005; Jin et al. 2001; Klose et al.
2002; Monks et al. 2004; Morley et al. 2004; Oleksiak et al.
2002; Schadt et al. 2003; Stranger et al. 2005). By exam-
ining the effects that naturally occurring variations in DNA
have on variations in gene expression traits in human or
experimental populations, other phenotypes (including
disease) can be examined with respect to these same DNA
variations and ultimately ordered with respect to genes to
infer causal control (Fig. 2) (Kulp and Jagalur 2006; Lum
et al. 2006; Mehrabian et al. 2005; Schadt et al. 2005). The
power of this integrative genomics strategy rests in the
molecular processes that transcribe DNA into RNA and
then RNA into protein, so that information on how varia-
tions in DNA impact complex physiologic processes often
ﬂows directly through transcriptional networks. As a result,
integrating DNA variation, transcription, and phenotypic
data has the potential to enhance identiﬁcation of the
associations between DNA variation and disease and
characterize those parts of the molecular networks that
drive disease.
Here we review different approaches for integrating
expression quantitative trait loci (eQTLs), expression, and
clinical data to infer causal relationships among gene
expression traits and between expression and disease traits.
We further review methods to integrate these data in a
more comprehensive manner by constructing coexpression
gene networks that leverage pairwise gene interaction data
to represent more general relationships. This type of net-
work provides a useful construct for characterizing the
topologic properties of biological networks and for parti-
tioning such networks into functional units (modules) that
underlie complex phenotypes like disease. However, these
networks are, by design, undirected and so do not explicitly
Fig. 2 Possible relationships between phenotypes with and without
genetic information. Edges between nodes in each of the graphs
represent an association between the nodes. A directed edge indicates
a causal association between the nodes. A A subset of the number of
possible relationships between three variables. In the case where one
of the three nodes in the network is a DNA locus (red nodes), many of
the graphs are no longer possible, given that directed edges from
expression trait to DNA locus are not possible. The red Xs highlight
edges that would not be allowed if the red node were a DNA locus. B
The ﬁrst three graphs represent the set of possible relationships
between two traits and a controlling genetic locus when feedback
mechanisms are ignored. The ﬁnal two graphs represent more
complicated scenarios in which multiple genetic loci control a given
trait that in turn drives a second trait or a single genetic locus drives
multiple traits that collectively drive another trait
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networks that capture causal information, we review
Bayesian network reconstruction algorithms that, like the
methods operating on only two or three expression traits
and/or clinical traits mentioned above, integrate eQTLs,
expression, and clinical phenotype data to reconstruct
whole-gene networks capable of representing direction
along the edges of the network. Here, directionality among
the edges corresponds to causal relationships among genes
and between genes and clinical phenotypes related to dis-
ease. These emerging high-dimensional data analysis ap-
proaches that integrate large-scale data from multiple
sources represent the ﬁrst steps in statistical genetics,
moving away from considering one trait at a time and to-
ward operating in a network context. Evolving statistical
procedures that operate on networks will be critical to
extracting information related to complex phenotypes like
disease as research goes beyond the single-gene focus. The
early successes achieved with some of the methods de-
scribed herein suggest that these more integrative genomics
approaches to dissecting disease traits will signiﬁcantly
enhance the identiﬁcation of key drivers of disease beyond
what could be achieved by genetics alone.
Leveraging the heritability of expression as a path to
reconstructing networks
Gene transcripts have been identiﬁed that are associated
with complex disease phenotypes (Karp et al. 2000;
Schadt et al. 2003), are alternatively spliced (Johnson
et al. 2003), elucidate novel gene structures (Mural et al.
2002; Schadt et al. 2004; Shoemaker et al. 2001), can
serve as biomarkers of disease or drug response (DePrimo
et al. 2003), lead to the identiﬁcation of disease subtypes
(Mootha et al. 2003; Schadt et al. 2003; van’t Veer et al.
2002), and elucidate mechanisms of drug toxicity (Waring
et al. 2001). Changes in gene expression often reﬂect
changes in a gene’s activity and the impact a gene has on
different phenotypes. Because gene expression is a
quantitative trait, linkage and association methods can be
directly applied to such traits to identify genetic loci that
control them. In turn, genetic loci that control for
expression traits may also associate with higher-order
phenotypes affected by expression changes in the gene of
interest, providing a path to directly identify genes con-
trolling for phenotypes of interest. Therefore, identifying
the heritable traits and the extent of their genetic vari-
ability provides insight about the evolutionary forces
contributing to the changes in expression that associate
with biological processes that underlie diseases like
obesity and diabetes, beyond what can be gained by
looking at the transcript abundance data alone.
It is now well established that gene expression is a sig-
niﬁcantly heritable trait (Alberts et al. 2005; Brem et al.
2002; Chesler et al. 2005; Cheung et al. 2005; Jansen and
Nap 2001; Monks et al. 2004; Morley et al. 2004; Petretto
et al. 2006a, b; Schadt et al. 2003, 2005). If a gene
expression trait is highly correlated with a disease trait of
interest, and if the corresponding gene physically resides in
a region of the genome that is associated with the disease
trait, then knowing that the expression trait is also geneti-
cally linked to a region coincident with its physical location
provides an objective and direct path to identify candidate
causal genes for the disease trait (Alberts et al. 2005; Brem
et al. 2002; Chesler et al. 2005; Cheung et al. 2005; Jansen
and Nap 2001; Monks et al. 2004; Morley et al. 2004;
Petretto et al. 2006a, b; Schadt et al. 2003, 2005). The ge-
netic information therefore enables the dissection of the
covariance structure for two traits of interest into genetic
and nongenetic components, and the genetic component can
then be leveraged to support whether an expression and
disease trait are related in a causal, reactive, or independent
manner (with respect to the expression trait). Elucidating
causal relationships is possible in this setting given the
unambiguous ﬂow of information from changes in DNA to
changes in RNA and protein function (Fig. 1). That is, gi-
ven that two traits are linked to the same DNA locus and a
few important simplifying assumptions, there are a limited
number of ways in which these two traits can be related with
respect to a given locus (GuhaThakurta et al. 2006; Schadt
2005; Schadt et al. 2005), whereas in the absence of such
genetic information, many indistinguishable relationships
would be possible, so that additional data would be required
to establish the correct relationships.
Leveraging DNA variation information to reconstruct
gene networks supposes that we are able to systematically
identify genetic loci that at least partially control transcript
abundances for genes of interest. This of course is
straightforward given that transcript abundance or gene
expression traits are quantitative measures that can be
analyzed like any other quantitative trait in a genetics
context. However, the difﬁculty in analysis and interpre-
tation comes with the large number of traits examined.
Microarrays are capable of monitoring tens of thousands
(or hundreds of thousands) of transcripts simultaneously.
Therefore, methods to compute eQTLs must consider
computational tractability given the need to run the anal-
yses potentially millions of times. In addition, signiﬁcance
thresholds must take into account multiple testing. Multiple
testing issues relate not only to the number of transcripts
tested but also to the number of markers or proportion of
the genome tested. However, the strong correlation struc-
ture that exists among many of the expression traits mon-
itored in a segregating population can be leveraged to
enhance the power to detect relationships among genes.
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to gene expression traits in segregating populations to
identify eQTLs and to establish relationships among genes
and between genes and disease traits, where multiple traits
at a time can be considered. Typical approaches to the joint
analysis of genetic traits involve mapping each gene
expression trait individually and inferring the genetic cor-
relation between pairs or sets of expression traits based on
pairwise Pearson correlation, eQTL overlaps, and/or tests
for pleiotropy. Using a family-based sample, Monks et al.
(2004) estimated the genetic correlation between pairs of
traits using a bivariate variance-component-based segre-
gation analysis and showed that the genetic correlation was
better able to distinguish clusters of genes in pathways than
correlations based on the observed expression traits. This
type of method can be extended to perform bivariate and
multivariate QTL analyses, which can be more highly
powered to detect QTLs when traits are correlated. Clusters
of correlated gene expression traits can often contain
hundreds or thousands of genes, which would be compu-
tationally prohibitive in a joint analysis. Kendziorski et al.
(2006) approached this problem in a different way by
employing a Bayesian mixture model to exploit the in-
creased information from the joint mapping of correlated
gene expression traits, which is computationally tractable
for large sets of genes. Instead of doing a linkage scan by
computing LOD scores at positions along the genome,
Kendziorski et al. (2006) computed the posterior proba-
bility that a particular gene expression trait maps to marker
m for each marker, as well as the posterior probability that
the trait maps nowhere in the genome. Nonlinkage in this
setting is declared for a transcript if the posterior proba-
bility of nonlinkage exceeds a threshold that bounds the
posterior expected false discovery rate (FDR). One beneﬁt
to this approach is that it controls false discovery for the
number of expression traits being tested, whereas assessing
the appropriate signiﬁcance cutoffs in single-transcript
linkage analysis often requires data permutation analyses.
The drawback of this method is that it assumes that linkage
occurs at either one or none of the markers tested and it
lacks a well-deﬁned method for the case when multiple
eQTLs control an expression trait.
In a study of inbred strain crosses, the only valid way of
estimating the extent of genetic control of a given trait is to
explicitly model each eQTL, including any epistatic
interactions if they exist. Brem and Kruglyak (2005)
showed that epistatic interactions were prevalent in the
gene expression levels in yeast, and similar suggestions
have been made in other species as well (Schadt et al.
2005), but more deﬁnitive studies are needed to charac-
terize the extent of epistasis among eQTLs in these other
species. In the absence of epistasis, the genetic contribution
for each transcript has been estimated by summing
contributions for each individual eQTL, assuming that little
or no allelic association exists between the eQTLs. In the
presence of epistasis, however, this practice cannot yield a
valid estimate, and multilocus models are instead required
to obtain valid estimates. In addition, multilocus modeling
can identify loci contributing to expression traits that
would have been missed in single-locus eQTL scans (Brem
and Kruglyak 2005; Storey et al. 2005).
Integrating eQTLs and clinical trait linkage mapping to
infer causality
While understanding the mechanisms of RNA expression is
in itself important for understanding biological processes,
the ultimate use of this information is identifying the
relationship between variation in expression levels and
disease phenotypes in an organism of interest. Microarray
experiments are commonly used to explore differential
expression between disease and normal tissue samples or
between samples from different disease subtypes. These
studies are designed to detect association between gene
expression and disease-associated traits, which in turn can
lead to the identiﬁcation of biomarkers of disease or dis-
ease subtypes. However, in the absence of supporting
experimental data, these data alone are not able to distin-
guish genes that drive disease from those that respond. As
discussed above, eQTL mapping can aid traditional clinical
trait QTL (cQTL) mapping by narrowing the set of can-
didate genes underlying a given cQTL peak and by iden-
tifying expression traits that are causally associated with
the clinical traits.
Expression traits detected as signiﬁcantly correlated
with a clinical phenotype may reﬂect a causal relationship
between the traits, either because the expression trait
contributes to, or is causal for, the clinical phenotype, or
because the expression trait is reactive to, or a marker of,
the clinical phenotype. However, correlation may also exist
in cases when the two traits are not causally associated.
Two traits may appear correlated due to confounding fac-
tors such as tight linkage of causal mutations (Schadt et al.
2005) or may arise independently from a common genetic
source. The A
y mouse provides an example of correlations
between eumelanin RNA levels and obesity phenotypes
induced by an allele that acts independently on these dif-
ferent traits, causing both decreased levels of eumelanin
RNA and an obesity phenotype. More generally, a clinical
and expression traits for a particular gene may depend on
the activity of a second gene in such a manner that con-
ditional on the second gene, the clinical and expression
traits are independent.
Correlation data alone cannot indicate which of the
possible relationships between gene expression traits and a
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123clinical trait are true. For example, given two expression
traits and a clinical trait detected as correlated in a popu-
lation of interest, there are 112 ways to order the traits with
respect to one another. If we consider the traits as nodes in
a network, then there are ﬁve possible ways the traits (or
nodes) can be connected: (1) connected by an undirected
edge, (2) connected by a directed edge moving left to right,
(3) connected by a directed edge moving right to left, (4)
connected by a directed edge moving right to left and a
directed edge moving left to right, and (5) not connected by
an edge. Since there are three pairs of nodes, there are 5 · 5
· 5 = 125 possible graphs. However, because we start with
the assumption that the traits are all correlated with one
another, we exclude 12 of the 125 possible graphs in which
one node is not connected to either of the other two nodes,
in addition to excluding the graph in which none of the
nodes are connected, leaving us with 112 possible graphs
(Fig. 2A). The joint trait distribution induced by these
different graphs are often statistically indistinguishable
from one another (i.e., they are Markov equivalent, so that
their distributions are identical), making it nearly impos-
sible in most cases to infer the true relationship. On the
other hand, when the two traits are at least partially con-
trolled by the same genetic locus and when more compli-
cated methods of control (e.g., feedback loops) are ignored,
the number of relationships between the QTLs and the two
traits of interest can be reduced to three basic models
illustrated graphically in Fig. 2B. The dramatic reduction
in the number of possible graphs to consider is mainly
driven by the fact that changes in DNA drive changes in
phenotypes and not vice versa. That is, while it may be
possible that changes in RNA or protein lead to changes in
DNA at a high enough frequency to detect associations
between germ-line transmitted DNA changes and pheno-
type in segregating populations, it seems extremely un-
likely.
It is important to note here that when we use the term
causality, it is perhaps meant in a more nonstandard sense
than most researchers in the life sciences may be accus-
tomed to. In the molecular biology or biochemistry setting,
claiming a causal relationship between, say, two proteins
usually means that one protein has been determined
experimentally to physically interact with or to induce
processes that directly affect another protein and that in
turn leads to a phenotypic change of interest. In such in-
stances, an understanding of the causal factors relevant to
this activity are known, and careful experimental manipu-
lation of these factors subsequently allows for the identi-
ﬁcation of genuine causal relationships. However, in the
present setting, the term ‘‘causal’’ is used from the stand-
point of statistical inference, where statistical associations
between changes in DNA, changes in expression (or
other molecular phenotypes), and changes in complex
phenotypes like disease are examined for patterns of sta-
tistical dependency among these variables that allows
directionality to be inferred among them, where the
directionality then provides the source of causal informa-
tion (highlighting putative regulatory control as opposed to
physical interaction). The graphical models (networks)
described here, therefore, are necessarily probabilistic
structures that use the available data to infer the correct
structure of relationships among genes and between genes
and clinical phenotypes (Schadt and Lum 2006). In a single
experiment with one time point measurement, these
methods cannot easily model more complex regulatory
structures that are known to exist, like negative feedback
control. However, the methods can be useful in providing a
broad picture of correlation and causative relationships,
and while the more complex structures may not be
explicitly represented in this setting, they are captured
nevertheless given that they represent observed states that
are reached as a result of more complicated processes like
feedback control.
Distinguishing proximal (‘‘cis’’) eQTL effects from
distal (‘‘trans’’)
All genes expressed in living systems are cis-regulated at
some level and so are under the control of various cis-
acting elements such as promoters and TATA boxes
(Fig. 3). In this context, expression as a quantitative trait
for eQTL mapping presents a unique situation in quanti-
tative trait genetics because the expression trait corre-
sponds to a physical location in the genome (the structural
gene that is transcribed, giving rise to the expression trait).
The transcription process operates on the structural gene,
and so DNA variations in the structural gene that affect
transcription will be identiﬁed as eQTLs in the mapping
process. In such cases eQTLs would be identiﬁed as cis-
acting, given that the most reasonable explanation for
seeing an eQTL coincident with the physical location of the
gene will be that variations within the gene region itself
give rise to variations in its expression (Doss et al. 2005).
However, because we cannot guarantee that the eQTL is
truly cis-acting (i.e., it could arise from variation in a gene
that is closely linked to the gene expression trait in ques-
tion), it is more accurate to refer to such eQTLs as proxi-
mal, given that they are close to the gene corresponding to
the expression trait. Because the cis-regulated components
of expression traits are among the most proximal traits in a
biological system with respect to the DNA (given that
RNA is transcribed from DNA), we might expect that true
cis-acting genetic variance components of expression traits
are among the easiest components to detect via QTL
analysis, if they exist. This indeed has been observed in
a number of studies in which proximal (presumably cis-
394 S.K. Sieberts and E.E. Schadt: Moving toward a system genetics view of disease
123acting) eQTLs have been identiﬁed that explain unprece-
dented proportions of a trait’s overall variance (several
published studies highlight examples where greater than
90% of the overall variation was explained by a single cis-
acting eQTL) (Brem et al. 2002; Cervino et al. 2005;
Cheung et al. 2005; Lum et al. 2006; Monks et al. 2004;
Schadt et al. 2003).
Variations in expression levels induced by DNA varia-
tions in or near the gene itself may in turn induce changes
in the expression levels of other genes (Fig. 3). Each of
these genes in a population of interest may not harbor any
DNA variation in their structural gene so that they do not
give rise to true cis-acting eQTL, but they nevertheless
would give rise to eQTLs that link to the gene region
inducing changes in their expression. Therefore, we see
that the individual variation in gene expression can be of
two fundamental types. The ﬁrst, termed proximal, often
results from DNA variations of a gene that directly inﬂu-
ence transcript levels of that gene. The second, termed
trans-acting or distal, does not involve DNA variations of
the gene in question but rather is secondary to alterations of
other true cis-acting genetic variations (Fig. 3). In reality,
variation in expression traits may be due to variation in cis-
acting elements and/or one or multiple trans-acting ele-
ments. In addition, master regulators of transcription,
which affect the expression of many traits in trans (Fig. 3),
may exist, though the evidence on this is not conclusive at
this point in all species, given the limited number of studies
and small sample sizes for all studies published to date.
In most cases it is not possible to infer the true regula-
tory effects (i.e., cis vs. trans) of an eQTL without complex
bioinformatics study (GuhaThakurta et al. 2006) and
experimental validation. As a result, eQTLs have been
categorized into proximal and distal types based on the
distance between the eQTL and the location of the struc-
tural genes. Obviously, if these are on different chromo-
somes the eQTLs are distal, but if they fall on the same
chromosome then they are considered proximal only if the
distance between the structural gene and the eQTLs do not
exceed some threshold. The exact threshold is a function of
the number of meioses and extent of recombination in a
given population data set. In a completely outbred popu-
lation where LD mapping has been used to ﬁne-map the
eQTLs, it has been reasonable to require the distance be-
tween the proximal eQTL and structural gene to be less
than 1 Mb (Cheung et al. 2005). However, in an F2 inter-
cross population constructed from two inbred lines of mice,
the extent of LD will be extreme given that all animals are
descended from a single F1 founder, with only two meiotic
events separating any two mice in the population. In such
cases the resolution of linkage peaks is quite low, requiring
the threshold of peak-to-physical gene distance to be more
relaxed, so that eQTLs that are within 20 or 30 Mb could
be potentially cis-acting (Doss et al. 2005; Schadt et al.
2003). While the proximal eQTLs provide an easy path to
making causal inference, given that the larger effect sizes
commonly associated with proximal eQTLs make them
easier to detect (Brem et al. 2002; Cervino et al. 2005;
Cheung et al. 2005; Lum et al. 2006; Monks et al. 2004;
Schadt et al. 2003), the methods discussed above work for
distal as well as proximal eQTLs. In fact, if a given gene
sits more centrally in a given gene network that drives
Fig. 3 Mapping proximal and distal eQTLs for gene expression
traits. The white rectangles represent genes that are controlled by
transcriptional units. The ellipses represent the transcriptional control
units, which could be transcription regulatory sites, other genes that
control the expression of the indicated gene, and so on. A Cis-acting
control unit acting on a gene. DNA variations in this control unit that
affected the gene’s expression would lead to a cis-acting (proximal)
eQTL. B Cis and trans control units regulating the indicated gene.
DNA variations in these control units that affected the gene’s
expression would lead to proximal and distal eQTLs. C Cis control
unit and multiple trans control units regulating the indicated genes.
DNA variations in these control units would lead to a complex eQTL
signature for the gene. D A single control unit regulating multiple
genes. DNA variations in this single control unit could lead to a
cluster of distal eQTLs (an eQTL hot spot)
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123disease, it may capture a larger percentage of the genetic
variation associated with the disease (Fig. 2B), making the
gene easier to identify and associate with disease. This was
the case in one of the ﬁrst studies to explicitly leverage
DNA and RNA changes to map genes for obesity (Schadt
et al. 2005). In that study three genes (C3ar1, Tgfbr2, and
Zfp90) were identiﬁed and validated as causal for obesity,
and in all three cases the QTLs that facilitated identiﬁca-
tion of the causal association were all distally acting with
respect to the expression traits.
More generally leveraging eQTL data to reconstruct
gene networks
The classic reductionist view applied to genetics has
motivated the identiﬁcation of single genes associated with
disease as one means of getting a foot into disease path-
ways. However, even in cases where genes are involved in
pathways that are well known, it is unclear whether the
gene causes disease via the known pathway or whether the
gene is involved in other pathways or more complex net-
works that lead to disease. This was the case with TGFBR2,
a recently identiﬁed and validated obesity susceptibility
gene (Schadt et al. 2005). The classic view of the signaling
pathways involving the superfamily of transforming
growth factor b (TGF-b) proteins is that TGF-b acts
through receptor serine/threonine kinases to phosporylate
regulatory proteins of the Smad family, which then move
into the nucleus where they bind DNA to activate speciﬁc
sets of target genes (Alberts 2002) (Fig. 4A). Although the
number of biological functions this cascade ultimately
impacts is large, the classic pathway is simplistic, involv-
ing only a limited number of genes, with little insight
provided into the vast network of gene interactions that
potentially modulate key players in this pathway.
RNA levels of the type II TGF-b receptor (TGFBR2)
were recently shown to be very signiﬁcantly correlated
with thousands of other gene expression traits in the liver
transcriptional network of a cross between two inbred lines
of mice (referred to here as the BXD cross) (Schadt et al.
2003, 2005) This set of genes associated with TGFBR2 was
enriched for a broad range of biological functions known to
be associated with the classic TGF-b signaling pathway
and with metabolic disease traits such as obesity. Fur-
thermore, TGFBR2 RNA levels in the BXD cross were also
found to be signiﬁcantly correlated with many obesity-re-
lated traits like fat mass, percent body fat, and weight.
Taking a view that a complex network of gene interactions
underlies obesity phenotypes in the BXD cross, genotypic
and gene expression data were systematically integrated to
assess whether changes in DNA sequence at a given
location in the genome (reﬂected as genotypes in the cross
animals) leading to changes in transcript abundances for a
given gene supported an independent, causative, or reactive
function of that gene relative to various obesity phenotypes
like fat mass (Schadt et al. 2005). In partitioning the
thousands of genes associated with obesity in this way,
TGFBR2 was one of 40 genes predicted as causal for
obesity in the BXD cross. TGFBR2 and two other genes
selected for validation were all validated as causal for
obesity in this study (Schadt et al. 2005). These data di-
rectly demonstrated that TGFBR2 and other genes in this
signaling pathway are involved in a more general gene
Fig. 4 Genes comprising
simple linearly ordered
pathways operate in a network
context. A The classic view of
TGF-b signaling (Alberts 2002)
involves Tgfbr2 as a key
component. Tgfbr2 was recently
identiﬁed and validated as an
obesity susceptibility gene. B
The genes comprising the TGF-
b signaling pathway are
correlated with hundreds of
other genes in the liver network
(Schadt et al. 2005) so that
components of this pathway
affect and are affected by many
different parts of the network
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123network (Schadt et al. 2005a, b), so that it is possible that
perturbations in these other genes or in TGFBR2 itself may
drive diseases like obesity by inﬂuencing other parts of the
network beyond the TGF-b signaling pathway (Fig. 4B).
Therefore, considering single genes in the context of a
whole-gene network may provide the necessary context
within which to interpret the disease role a given gene may
play.
Networks provide a convenient framework for exploring
the context within which single genes operate. Networks
are simply graphical models comprising nodes and edges.
For gene networks associated with biological systems, the
nodes in the network typically represent genes, and edges
(links) between any two nodes indicate a relationship be-
tween the two corresponding genes. For example, an edge
between two genes may indicate that the corresponding
expression traits are correlated in a given population of
interest (Zhu et al. 2004), that the corresponding proteins
interact (Kim et al. 2005), or that changes in the activity of
one gene lead to changes in the activity of the other gene
(Schadt et al. 2005). Interaction or association networks
have recently gained more widespread use in the biological
community, where networks are formed by considering
only pairwise relationships between genes, including pro-
tein interaction relationships [49], coexpression relation-
ships (Gargalovic et al. 2006; Ghazalpour et al. 2006), and
other straightforward measures that may indicate associa-
tion between two genes.
Genetic data can aid in the construction of association
networks by helping to reduce artifactual correlations be-
tween expression traits. Signiﬁcant artifactual correlations
can arise because of correlated noise structures between
array-based experiments networks. One way to leverage
the eQTL data in this setting is to simply ﬁlter out gene-
gene correlations in which the expression traits are not at
least partially explained by common genetic effects (Lum
et al. 2006). For example, we can connect two genes with
an edge in a coexpression network if (1) the p value for the
Pearson correlation coefﬁcient between the two genes is
less than some prespeciﬁed threshold, and (2) the two
genes had at least one eQTL in common. This can be taken
a step further by formally assessing whether two expression
traits driven by a common QTL are related in a causal or
reactive fashion, ﬁltering out correlations driven by
expression traits that are independently driven by common
or closely linked QTLs (Doss et al. 2005; Schadt et al.
2005).
As has been discussed, multiple traits driven by common
QTLs is a central idea that can be leveraged to construct
networks. One intuitive way to establish whether two genes
share at least one eQTL is to perform single-trait eQTL
mapping for each expression trait and then consider eQTLs
for each trait overlapping if the corresponding LOD for the
eQTLs are above some threshold and if the eQTLs are in
close proximity to one another. The signiﬁcance of the
statistic corresponding to the strength of association be-
tween two genes in the coexpression networks is then
chosen such that the resulting network exhibits the scale-
free property (Gargalovic et al. 2006; Ghazalpour et al.
2006; Lum et al. 2006) and the false discovery rate for the
gene-gene pairs represented in the network is constrained.
Beyond the simple, albeit intuitively appealing, eQTL
overlap method, we can formally test whether two over-
lapping eQTLs represent a single eQTL or closely linked
eQTLs by employing a pleiotropy effects test (PET), such
as that originally described by Jiang and Zeng (1995) and
Zeng et al. (2000). The formation of gene clusters by
simultaneously considering gene-gene and marker-gene
correlations also promises to provide a more comprehen-
sive characterization of shared genetic effects (Lee et al.
2006).
Identifying modules of highly interconnected genes in
coexpression networks
Given the scale-free and hierarchical nature of coexpres-
sion networks (Barabasi and Oltvai 2004; Ghazalpour
et al. 2006; Lum et al. 2006), one of the key problems is
to identify the network modules, or functional units, in
the network that represent those hub nodes (nodes that are
signiﬁcantly correlated with many other nodes) that are
highly interconnected with one another but that are not as
highly connected with other hub nodes. Figure 5 illus-
trates a topological connectivity map for the most highly
connected genes in the adipose tissue of the BXH cross
(E. E. Schadt et al., unpublished). After hierarchically
clustering both dimensions of this plot, the network is
seen to break out into clearly identiﬁable modules. Gene-
gene coexpression networks are highly connected, and the
clustering results shown in Fig. 5 illustrate that there are
gene modules arranged hierarchically within these net-
works.
Ravasz et al. (2002) used manually selected height
cutoff to separate tree branches after hierarchical cluster-
ing, in contrast to Lee et al. (2004) who formed maximally
coherent gene modules with respect to gene ontology (GO)
functional categories. Another strategy is to employ a
measure similar to that used by Lee et al. (2004) but
without the dependence on the GO functional annotations,
given it is of interest to determine independently whether
coexpression modules are enriched for GO functional
annotations (Lum et al. 2006). The modules identiﬁed in
this way are informative for identifying the functional
components of the network that are associated with disease
(Lum et al. 2006). It has been demonstrated that the types
of modules depicted in Fig. 5 are enriched for known
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traits, and for genes that are linked to common genetic loci
(Ghazalpour et al. 2006; Lum et al. 2006). In this way, one
can identify those key groups of genes that are perturbed by
genetic loci that lead to disease, and that therefore deﬁne
the intermediate steps that actually deﬁne disease states.
Using eQTL data to reconstruct probabilistic networks
Coexpression networks are useful constructs for character-
izing gross topological properties of biological networks,
highlighting nodes that are highly connected, and identi-
fying functional modules that aid in the characterization of
subnetworks associated with disease. The edges in these
networks, however, are undirected so that they do not pro-
vide explicit details on the connectivity structure among
genes in the network. As suggested above, one way to
incorporate causal information into the coexpression net-
works would be to deﬁne direction using the causality
procedures described in Fig. 2B. However, such a method
would be limited by considering only pairs of genes at a
time. The naturally occurring variations in DNA can be
leveraged more generally as a systematic source of pertur-
bations to infer causal associations among gene expression
traits and between gene expression and clinical traits,
moving us toward the ultimate goal of reconstructing
whole-gene networks that drive disease, so that for any
given gene a more complete context is deﬁned. Zhu et al.
(2004) were among the ﬁrst to formally incorporate genetic
data into the reconstruction of whole-gene networks using
Fig. 5 Coexpression and Bayesian networks from adipose expression
data collected in a murine F2 intercross population. The upper-left
panel is a topological overlap map view of the adipose coexpression
network. All pairs of correlations among the 5000 most highly
connected genes in the adipose data are plotted in the color matrix
display (red indicates positive correlation, blue indicates negative
correlation, and white indicates correlation not signiﬁcant at the p <
10
-20 level). The genes are ordered along the x and y axes using an
agglomerative hierarchical clustering algorithm. Tightly correlated
groups of genes (modules) clearly emerge from this plot. Modules are
identiﬁed as described in the text. The upper-right panel is the
Bayesian network corresponding to genes in module 2 highlighted in
the topological overlap map. The lower-left panel represents a
subnetwork consisting of 36 genes that contain the genes Lpl and
Lactb recently validated as causal for obesity (E. E. Schadt et al.,
unpublished). More generally, module 2 highlighted in the topolog-
ical overlap map contains a number of genes validated as causal for
obesity (lower-right panel), indicating that disease-causing genes may
cluster into functionally coherent sets in the network
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works are directed acyclic graphs that, while limited with
respect to representing temporal information or feedback
loops, allow for the explicit representation of causal asso-
ciations among nodes in the network. With Bayesian net-
work reconstruction methods taking gene expression data as
the only source of input, many relationships between genes
in such a setting will be Markov equivalent (symmetric),
similar to what was discussed for three-node graphs in
Fig. 2. This means one cannot statistically distinguish
whether a given gene causes another gene to change or vice
versa. To break this symmetry, Zhu et al. (2004) incorpo-
rated eQTL data as prior information to establish more
reliably the correct direction among expression traits.
Bayesian network methods have been applied previ-
ously to reconstruct networks comprising only expression
traits, and to networks comprising both expression and
disease traits, where the aim has been to identify those
portions of the network that are driving a given disease
trait. Forming candidate relationships among genes was
performed using an extension of standard Bayesian net-
work reconstruction methods (Chiellini et al. 2002). In the
ﬁrst approach to extend this method using genetic data,
QTL information for the transcript abundances of each
gene considered in the network was incorporated into the
reconstruction process. It is well known that searching for
the best possible network linking a moderately sized set of
genes is an NP-hard problem. Exhaustively searching for
the optimal network with hundreds of genes is presently a
computationally intractable problem. Therefore, various
simpliﬁcations are typically applied to reduce the size of
the search space and to reduce the number of parameters
that need to be estimated from the data. Two simplifying
assumptions to achieve such reductions are commonly
employed. First, while any gene in a biological system can
control many other genes, a given gene can be restricted so
that it is allowed to be controlled by a reduced set of genes.
Second, the set of genes that can be considered possible
causal drivers (parent nodes) for a given gene can be re-
stricted using the type of causality arguments discussed in
previous sections, as opposed to allowing for the possibility
of any gene in the complete gene set to serve as a parent
node. The eQTL data in this case can be leveraged as prior
information to restrict the types of relationships that can be
established among genes and the QTL information can be
more intimately integrated into the network reconstruction
process. As indicated in previous sections, correlation
measures are symmetric and so can indicate association but
not causality. However, QTL mapping information for the
gene expression traits can be used to help sort out causal
relationships. The different tests described in the section on
making causal inferences between pairs of traits provides
one way to explicitly sort out such relationships. Zhu et al.
(2004) leveraged the eQTL data in a different way to make
similar types of inferences in their network reconstruction
algorithm.
With the various constraints and measures deﬁned
above, the goal in reconstructing whole-gene networks is to
ﬁnd a graphical model M (a gene network) that best rep-
resents the relationships between genes, given a gene
expression data set D of interest. That is, given data D,w e
seek to ﬁnd the model M with the highest posterior prob-
ability P(M|D). The prior probability P(M) of model M is
PðMÞ¼
Y
X!Y
PðX ! YÞ
where the product is taken over all paths in the network (M)
under consideration. The algorithm Zhu et al. (2004) em-
ployed to search through all possible models to ﬁnd the
network that best ﬁts the data is similar to the local max-
imum search algorithm implemented by Friedman et al.
(2000). Zhu et al. (2007) recently demonstrated via simu-
lation of biologically realistic networks that the integration
of genetic and expression data in this fashion to reconstruct
gene networks leads to networks that are more predictive
than networks reconstructed from expression data alone.
The Bayesian network reconstruction algorithm can be
used to elucidate the module connectivity structure depicted
inFig. 5.BecausereconstructionofBayesian networksisan
NP-hard problem (Garey and Johnson 1979), the number of
nodesthatcanbeconsideredinthenetworkandtheextentof
connections (edges) among these nodes must be reduced
(overwhatcanbeconsideredinreconstructingcoexpression
networks) to make the problem tractable, thereby making
such networks more sparse compared with coexpression
networks. Toward this end, Fig. 5 shows the result of the
Bayesian network reconstruction algorithm discussed above
applied to module 2 of the coexpression network depicted in
Fig. 5. Further highlighted in Fig. 5 is a subnetwork con-
taining the gene Lpl, a gene recently identiﬁed as causal for
obesity in the BXH cross (E. E. Schadt et al., unpublished).
Infact,themodule2subnetworkcontainsanumberofgenes
recently identiﬁed and validated as causal for obesity
(Fig. 5). The more detailed structure provided by the dif-
ferent networks depicted in Fig. 5 allows for the examina-
tion of the context in which speciﬁc genes like Lpl operate,
providing insights into which parts of the network may
impact a given gene’s function and what other parts of the
network may be impacted by the gene’s function.
Conclusions
The identiﬁcation of DNA polymorphisms that associate
with diseases like obesity and diabetes can be considered
only as the beginning in a long series of steps needed to
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individual genes may play in the process. Diseases like
obesity are diseases of the system, potentially involving
many different pathways operating in many different tis-
sues and ultimately giving rise to not only different disease
subtypes but to different comorbidities of the disease as
well. The integration of gene expression (and other
molecular proﬁling data more generally) and genotypic
data will be critical if we are ever to understand how ge-
netic and environmental perturbations to a given system
lead to complex traits like disease. If common forms of
these diseases represent states of a network, then focusing
on single-gene perturbations will likely never reveal the
most effective ways to treat or prevent disease.
The integration of the diverse sets of molecular data now
being generated in population settings is only in its infancy.
Many of the methods employed to date toward this end are
more heuristic in nature and so will beneﬁt from a more
formal treatment. In addition, little to date has been done to
integrate expression data from multiple tissues to dissect
how modules in one tissue may communicate with modules
in another tissue. The types of interactions considered along
with eQTL data so far have been restricted to RNA-RNA
association data, despite the availability of large-scale
DNA-protein and protein-protein interaction data. The
predictive power of the types of networks discussed in this
review could be enhanced by more systematically inte-
grating protein-protein interactions, protein-DNA interac-
tions, protein-RNA interactions, RNA-RNA interactions,
protein state information, methylation state, and interac-
tions with metabolites as these types of data become
available. These developments promise to take us beyond
the single-gene view of disease and move us closer to the
type of systems level view, depicted in Fig. 1, that may be
needed to fully understand the complexity of common hu-
man diseases like obesity and diabetes. Of course, further
study and experimentation are needed to demonstrate more
convincingly that understanding the state of a given
molecular network, interactions among molecular net-
works, and how the states of such networks change in re-
sponse to different genetic and environmental contexts is
tractable enough to take us beyond the reductionist ap-
proach, which to date has achieved great success in eluci-
dating the complexity of living systems more generally.
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